Celea Therapeutics

Advancing transformative treatments for serious respiratory diseases

Celea Therapeutics is a biotech company in Boston, United States, founded in 2025. It has raised $255.0M across 2 rounds, most recently a $180.0M Series B in July 2026.

Employees
11–50
Founded
2025
Business Model
B2B
Total Funding
$255.0M
Last Round
$180.0M Series BJul 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. to use credits for reveals, or explore the API.

About

Celea Therapeutics is a clinical-stage biopharmaceutical company dedicated to advancing transformative treatments for serious respiratory diseases, founded by PureTech Health in 2025. Its lead program, deupirfenidone (LYT-100), is a next-generation antifibrotic entering Phase 3 development for idiopathic pulmonary fibrosis (IPF), designed as a strategically modified version of an approved IPF therapy with the potential to become the new standard of care. The company's landmark SURPASS-IPF trial is the first industry-sponsored head-to-head Phase 3 trial in IPF.

Funding History

Data from Indexed.vcUpdated
Series BSeries BJul 2026
$180.0M

1 more funding event

  • Seed20261 investor

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Frontend ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Celea Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/celea-therapeutics"><img src="https://indexed.vc/api/badge/company/celea-therapeutics" alt="Celea Therapeutics on Indexed.vc" width="260" height="76" /></a>